Agnieszka Czechowicz

Dr. Agnieszka Czechowicz is an Assistant Professor at Stanford University. She is a pediatric hematologist/oncologist and sub-focuses on pediatric stem cell transplantation. She also runs a translational research group focusing on understanding hematopoietic stem cells and how they interact with their microenvironments. Agnieszka completed her residency in Pediatrics at Boston Children's Hospital and pursued fellowship training at the Dana Farber Cancer Institute and Lucile Packard Children's Hospital. She consulted for Third Rock ventures and incubated numerous companies including Editas, Magenta Therapeutics, and Global Blood Therapeutics, and currently advises GV. She graduated from Stanford University School of Medicine with an MD/Ph.D. in developmental biology in the Medical Scientist Training Program, in record-breaking time. She also earned an undergraduate degree with honors from Stanford University, in biological sciences and received the Firestone Medal for her outstanding senior thesis. Agnieszka is an author on numerous publications, including the first author on a paper published in the November 2007 issue of Science which shows a possible way to eliminate the toxicity of bone marrow transplantation (BMT), a discovery that could expand the applications of BMT to include cures for most blood diseases, as well as autoimmune diseases like diabetes. She is in the process of translating these discoveries and developing them into new therapies for patients.